Waldencast plc (NASDAQ:WALD – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 710,500 shares, a growth of 20.4% from the September 30th total of 590,300 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average daily trading volume, of 210,500 shares, the days-to-cover ratio is currently 3.4 days.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the company. Telsey Advisory Group reissued an “outperform” rating and set a $6.00 price target on shares of Waldencast in a research report on Wednesday, October 9th. Canaccord Genuity Group began coverage on Waldencast in a report on Friday, October 25th. They set a “buy” rating and a $5.00 target price for the company. Canaccord Genuity Group began coverage on shares of Waldencast in a report on Friday, October 25th. They issued a “buy” rating and a $5.00 price target on the stock. Finally, DA Davidson boosted their price objective on shares of Waldencast from $6.50 to $7.25 and gave the stock a “buy” rating in a research note on Wednesday, September 4th.
Get Our Latest Stock Analysis on Waldencast
Institutional Investors Weigh In On Waldencast
Waldencast Price Performance
NASDAQ:WALD opened at $3.95 on Wednesday. Waldencast has a 12 month low of $2.40 and a 12 month high of $12.00. The business’s 50-day moving average is $3.58 and its two-hundred day moving average is $3.85. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
See Also
- Five stocks we like better than Waldencast
- Differences Between Momentum Investing and Long Term Investing
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- What Investors Need to Know About Upcoming IPOs
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Which Wall Street Analysts are the Most Accurate?
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.